About: acn

MyFintech Week 2025 Highlights Transformative Forces in FinanceMyFintech Week 2025 (MyFW 2025) highlights the forces reshaping the financial sector through digitalisation, sustainability and demographic shifts.The event features experts on key issues in finance, such as digitalisation and innovation, financial inclusion and sustainability.The four-day event showcases transformational insights from thought leaders and masterclasses by industry experts.KUALA LUMPUR, Aug 6, 2025 - (ACN Newswire via SeaPRwire.com) - MyFW 2025 spotlights the forces reshaping the financial sector – digitalisation, sustainability and demographic shifts. Emerging technologies such as generative AI and blockchain are transforming business models and redefining consumer expectations. Malaysia’s commitment to achieving net-zero emissions is also driving demand for innovative financial solutions. In addition, the challenges posed by an ageing population stress the need for inclusive policies in long-term welfare, healthcare and social protection.Reflecting these realities, MyFW 2025 is structured around three thematic tracks. From closed-door dialogues to expert-led masterclasses and in-depth focus sessions, these themes form the week’s conversations:‘Finance for the Future’ focuses on building a digitally enabled and forward-looking financial system;‘Finance for Change’ supports sustainability and social impact; and‘Finance for a Resilient Ecosystem’ aims to strengthen financial system resilience.Held from 4 to 7 August 2025 at Sasana Kijang and AICB Centre of Excellence, MyFW 2025 is co-organised by Bank Negara Malaysia (BNM), Securities Commission Malaysia (SC), Asian Institute of Chartered Bankers (AICB), Fintech Association of Malaysia (FAOM) and Malaysia Digital Economy Corporation (MDEC). The event brings together regulators, financial institutions, digital banks, fintech innovators, technology providers, policymakers, investors and academia for bold conversations, practical insights and regional alignment.The event was officiated by Yang Berhormat Datuk Seri Amir Hamzah Azizan, Minister of Finance II. “The financial sector must play a more active role in shaping outcomes that matter to society in the years ahead, supporting these new growth areas, broader entrepreneurship and innovation, as well as fostering economic resilience and social mobility,” he said during his Special Address.The event started with a series of high-level keynotes exploring innovation, inclusion and regulatory clarity. In his opening remarks, BNM Governor Dato’ Sri Abdul Rasheed Ghaffour outlined the importance of collaboration in shaping the future of finance, which requires a whole-of-ecosystem solution. “The future we are building demands that policymakers, regulators, technologists, investors and innovators sit at the same table,” he said.Former central banker and Chairman of George Town Institute of Open and Advanced Studies Tan Sri Andrew Sheng, in his keynote themed “Unlocking Tomorrow: Transformative Innovations in Financial Services”, explored how pivotal technologies, including cloud computing, AI and open data are rapidly transforming the financial landscape. Douglas Feagins, President of Ant International explored the mobile interoperability between different countries and how AI is redefining cross-border transactions and user experiences in digital payments, in his keynote on “Beyond Borders: Mobile Payment in AI Era”.The flagship panel session, “Navigating the Fintech Frontier: Bridging Innovation and Regulation”, gathered central bank governors and financial regulators from across the region. Moderated by Erik Feyen, Head of Global Macro-financial Monitoring at the World Bank, the panel featured Dato’ Sri Abdul Rasheed Ghaffour, Dato’ Mohammad Faiz Azmi, Executive Chairman of SC, Eddie Yue, Chief Executive of the Hong Kong Monetary Authority, and Chia Der Jiun, Managing Director of the Monetary Authority of Singapore. The discussion focused on balancing innovation with consumer trust and the growing need for cross-border collaboration to ensure coherent, future-ready policy frameworks.“Regulatory clarity is essential for fostering responsible innovation, but equally important is the ability to stay agile. Our experience with crypto asset regulation highlights the need for an iterative approach to address fast-paced innovation and market evolution,” Dato’ Faiz said.“We are advancing the next iteration of our approach to digital assets to build a stronger regulated market, boosting competitiveness, resilience, and investor protection. Through regulatory support and ecosystem partnership, we are also facilitating blockchain use cases like bond tokenisation to broaden retail access and democratise wealth creation."The conference features an exciting lineup of sessions on topics including open finance, digital assets and sustainable finance. Participants can also look forward to focused sessions delivered by key partners and industry experts, which will provide in-depth exploration of issues, such as asset tokenisation, generative AI and cybersecurity resilience.About MyFintech WeekMyFintech Week (MyFW) is Malaysia’s flagship finance and innovation event co-organised by Bank Negara Malaysia, Securities Commission Malaysia, Asian Institute of Chartered Bankers (AICB), Malaysia Digital Economy Corporation (MDEC) and Fintech Association of Malaysia. The event brings together leaders, policymakers and innovators to shape the future of finance and serves as a launchpad for collaboration and progress toward a more inclusive, innovative and resilient financial ecosystem.For media enquiries (The appointed PR agency of MyFW 2025):Nazira Yusof, Client ExecutivePRecious Communications+6 011 6230 3806nazira@preciouscomms.com Copyright 2025 ACN Newswire via SeaPRwire.com.

賓州費城, 2025年8月6日 - (亞太商訊 via SeaPRwire.com) - TruMerit 是全球領先的健康從業人員國際資歷評估機構，今日正式推出 「全球認證護士（Certified Global Nurse，簡稱 CGN）」，這是全球首個真正面向初級、普通護士（註冊護士，RN）的國際認證。TruMerit｜全球職涯，關懷無界。這項全新、基於能力的國際認證，對來自任何國家的合格護理人員開放，旨在認可他們的專業能力，不論他們選擇在何處生活與工作。該認證需通過 TruMerit 的 護士資格考試（Nurse Qualifying Exam，簡稱 NQE） 方可獲得。申請人須在完成其護理教育與執業證照的驗證後，方可參加該考試。此考試前身為 CGFNS 資格考試，原本用於計劃移居美國的護理人員。如今，NQE 已重新設計，著眼全球視野，旨在支持全球護理實踐的持續發展，特別是因應數位健康、心理健康與氣候變遷等重要新興挑戰。這一轉型透過一項合作程序實現，共有來自 50 個國家的 70 多位護理專家參與，涵蓋世界衛生組織所有地區與世界銀行定義的各收入水平國家。這些專家在分析了來自 37 個國家的護理能力框架後，就一套核心護理實踐標準達成共識。除了作為全球註冊護士認證（CGN）的一項關鍵要求外，升級後的考試亦將繼續支援 TruMerit 的其他項目，例如 VisaScreen® 簽證資格評估服務及 Certification Program® 認證項目，作為一個共通的全球框架，用於驗證全球護理人員的應用知識與實務能力。TruMerit 總裁兼執行長 Peter Preziosi 博士表示：「全球註冊護士認證為世界各地的護士提供一個共同的框架，以達成全球一致認可的基本護理實踐標準。當護士持有此一認證時，他們的雇主與同事便能確信其所具備的應用護理知識與技能，已經通過全球基準的驗證，證明其具備提供高品質醫療服務的專業能力。」此項認證的最終目標，是為護理人員在其專業領域、本國及跨越地緣政治邊界的職涯流動性提供更大支持。Preziosi 表示：「透過在國際層面展現工作準備度，並擴大全球可識別的合格護理人力資源，全球認證將成為協助世界各地醫療體系解決挑戰的一部分。」他補充說：「我們希望此項認證能促成一項持續的全球協作行動，匯聚各方利害關係人──包括衛生部門、國際機構、醫療體系、護理學校與全球各地護理協會──共同推動護理教育與實踐的標準化，並支持全球護理人力的長期發展。」護士資格考試（NQE）為監考制考試，每年舉辦四次，考場遍布全球 1,000 多個 Kryterion 測驗中心。首次考試時段定於 2025 年 11 月 10 日至 14 日。欲取得 CGN 認證並參加 11 月考試的護理人員，必須於 9 月 30 日前 前往TruMerit 官網 提交申請。網站上將提供更多關於認證資訊及考試準備內容。2026 年的考試時間表將於今年稍晚公布。關於 TruMeritTruMerit 是全球領先的醫療人力發展機構。前身為 CGFNS International，該組織擁有近 50 年歷史，致力於協助護理人員與其他醫療工作者——以及負責發照與聘用的機構——在尋求在美國及其他國家執業許可時，驗證其教育背景、專業技能與實務經驗，促進其職涯流動性。作為 TruMerit，該機構的使命已擴展為建立符合全球快速變遷健康需求的人力資源能力。透過旗下的全球健康人力發展研究院（Global Health Workforce Development Institute），TruMerit 正在推動以實證為基礎的研究、思想領導與倡議，支持各項醫療人力發展方案，包括全球認可的執業標準與認證，藉此強化醫療工作者的職涯發展途徑。 联系信息 David St. John dstjohn@trumerit.org聯絡資訊David St. Johndstjohn@trumerit.org來源: TruMerit Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月6日 - (亞太商訊 via SeaPRwire.com) - 香港中文大學(中大)宣佈該校多學科團隊與香港創新型手術機械人獨角獸企業康諾思騰（Cornerstone Robotics）攜手，成功開發全球首個手術機械人多功能自動化具身智能平台。平台並在康諾思騰自主研發的Sentire思騰®腔鏡手術機械人上，完成了全球首例臨床場景下的自主手術驗證，相關研究成果獲機器人領域權威期刊《Science Robotics》發表，《Science Robotics》期刊由《Science》雜誌旗下出版，最新影響因數為27.5，五年影響因數達32.9，是全球機器人研究領域最具影響力的學術平台之一。相關研究成果以〈Surgical Embodied Intelligence for Generalized Task Autonomy in Laparoscopic Robot-assisted Surgery〉為題，由中國自主研發的腔鏡手術機械人在具身智能領域中，首次完成活體動物實驗，並驗證多工自主操作與人機協作能力，驗證了演算法的通用性與系統的臨床可行性，將引領行業朝着更智慧、更協同、更普惠的方向加速演進。研究構建了一種面向手術任務自動化的具身智能新範式--VPPV（Visual Parsing, Perceptual Regressor, Policy Learning, Visual Servoing Controller），通過融合視覺基礎大模型的穩健感知能力、強化學習範式的策略泛化能力，以及AI策略與傳統控制的分層融合架構，使手術機械人自主操作在穩定性、靈活性與可反覆運算性方面實現新突破。有別於傳統手術自動化方法中，對額外感測器輸入或基於人工預設定義規則與模型依賴的局限性，該研究成果是全球首創的手術具身智能框架，兼具全景感知、多工泛化、精細伺服閉環以及人機協同的功能特點，可大幅降低研發與臨床應用門檻，為下一代智慧手術助手樹立新標杆。研究團隊基於自主研發的開源模擬平台SurRoL訓練出多項具備泛化能力的AI策略，並成功實現「零樣本遷移」，該平台集成多模態感知、真實物理建模與多工操作訓練，覆蓋手術機械人控制介面、模擬環境與強化學習引擎。為了更接近真實的手術環境，研究團隊分別使用離體豬胃組織（保留完整的胃網膜血管）和約30公斤活體豬模型進行了嚴格的驗證實驗，兩次實驗均由康諾思騰自主研發的Sentire思騰®腔鏡手術機械人系統完成。在活體動物驗證階段，實驗採用了創新的「監督自主性（supervised autonomy）」安全模式，以Sentire思騰®腔鏡手術機械人的高清立體內窺鏡系統，無需任何額外感測器，即自主完成了紗布拾取、軟組織牽引和血管夾閉等機械人手術輔助核心任務的操作，體現出高度的環境適應性、操控穩定性，以及臨床轉化的巨大潛力，為「人機共創」的具身智能外科手術協作模式提供現實支撐。康諾思騰聯合創始人、首席技術官兼首席運營官王澤睿博士作為本次研究的通訊作者表示：「Sentire思騰®腔鏡手術機械人作為本次研究的核心系統之一，具備機械架構、電氣架構、軟體架構、機械人演算法、圖像信號處理以及高等能量控制等全棧自研的核心技術，這套商業整機手術機械人系統為AI自主方案在動態手術環境中的穩定部署和高精度運行提供了有力的保障。」他進一步指出：「康諾思騰始終堅持全棧自研與垂直整合的研發戰略，我們的底層技術、軟硬體自主開發及系統集成優勢，使核心產品系統架構具備卓越的可擴展性，展現出獨特的AI就緒及AI友好特性。這不僅支援演算法快速適配和部署，也確保機械人系統能夠靈活應對不同任務需求與組織場景，真正為智慧化手術發展提供了堅實平台。」作為本項研究的技術合作方，康諾思騰團隊與香港中文大學研究團隊密切配合，成功在自主研發的Sentire思騰®腔鏡手術機械人上完成了演算法部署和活體動物驗證。這一成果不僅驗證了平台的開放架構與高度相容性，更標誌著AI手術輔助技術正加速走出實驗室，進入臨床轉化的前沿。康諾思騰創始人兼首席執行官歐國威教授表示：「我們始終相信，科研與產業的深度融合是推動高端醫療裝備技術突破的關鍵動力。此次合作不僅驗證了具身智能演算法在商用手術機械人平台上的實際落地能力，也體現出其在手術自動化領域的巨大應用潛力。我們將繼續攜手全球科研與臨床夥伴，共同探索複雜任務自動化、人機協作新範式與智慧系統監管機制，加速推動具身智能手術機械人走向真實臨床。」關於康諾思騰（Cornerstone Robotics）康諾思騰（Cornerstone Robotics）是香港本地創新型手術機械人的獨角獸企業，懷著「引領醫療創新，心繫天下健康」的願景，致力於打造安全高效的手術機械人平台，提升香港乃至全球範圍優質醫療資源的可及性，讓更多患者受益於高端醫療科技帶來的高品質醫療服務。公司已在全球設立四大研發中心，並在中國香港、深圳、北京、上海和美國波士頓、英國樸次茅斯設有分支機構，在粵港澳大灣區建成超萬平米的量產工廠。憑藉雄厚的技術實力，公司已成功突破技術難題，搭建全面底層技術平台，由康諾思騰自主研發的Sentire思騰®腔鏡手術機械人已完成多個重要專科的臨床試驗，並正式獲得中國國家藥品監督管理局（NMPA）批准上市，同步在全球範圍申請醫療器械認證，服務全球醫護，惠及更多病患。如欲瞭解更多，可瀏覽：https://en.csrbtx.com/ Copyright 2025 亞太商訊 via SeaPRwire.com.

2025年8月6日 - (亞太商訊 via SeaPRwire.com) - 品創控股有限公司（「品創控股」或「公司」，連同其附屬公司統稱為「集團」；股份代號：8066）欣然宣佈，集團電子商務業務持續高速增長，取得突破性佳績。根據集團的全資附屬公司山西動創數娛科技集團有限公司（「山西動創」）及賽博幻境（香港）有限公司（「賽博幻境」）各自的未經審核管理賬目，截至2025年6月30日止六個月，電子商務業務及人工智能（AI）業務的未經審核總收入及未經審核除稅前溢利總額分別達約6,090萬港元及5,560萬港元，反映集團電子商務業務增長之快速，以及前瞻佈局人工智能領域的成功。集團的電子商務業務涵蓋泛娛樂數字生態系統會員電子商務平台 ─ 動創電商APP服務平台之運營，以及通過人工智能平台提供語音技術相關服務。集團一直銳意多元化發展業務組合，以把握發展蓬勃的數字經濟及人工智能應用新發展商機。為促進業務拓展，集團於2024年收購山西動創，不僅引入具備豐富經驗和客戶資源雄厚的互聯網運營團隊，更藉此構築私域流量運營的競爭優勢，為集團進軍AI領域及業務升級轉型注入強勁動能。私域電商平台的成功運營，不僅驅動集團業績快速成長，更為集團累積逾10萬名忠實會員。這些會員在賽博幻境的人工智能語音技術資料採集與標註業務中，將轉化為逾10萬的語音素材貢獻者，此舉將加速推動集團轉型升級為人工智能數據服務企業。集團電子商務業務及人工智能業務的卓越表現不僅標誌著業務發展的重要里程碑，更為集團把握不斷增長的電子商務平台行業及人工智能業務機遇奠定堅實基礎。展望未來，集團將繼續深耕私域電商平台運營及人工智能業務，全方位拓展電子商務業務，持續強化核心優勢，全力推動業務實現高質量發展。同時，集團將繼續尋求合適的投資機會，進一步提升集團的增長潛力，致力為股東創造可持續的回報。關於品創控股有限公司品創控股有限公司的使命是妥善運用公司所獲得的資本與獨特投資機會，為股東提供穩定的優渥收入與獲利。品創由六個主要事業部門組成，包括智能卡製造服務、電子商務、人工智能、投資服務、資源回收投資與媒體與娛樂投資，主要業務為生產及銷售智能卡、提供定製智能卡應用系統、私域電子商務平台營運、人工智能語音技術數據服務、提供財務及管理諮詢服務、廢舊金屬銷售及貿易、以及媒體與娛樂行業之投資。公司的總部位於香港，旗下控股公司與投資則遍佈大中華地區。關於山西動創數娛科技集團有限公司山西動創數娛科技集團有限公司（前稱「海南動創數娛科技集團有限公司」）從事運營泛娛樂數字生態系統會員電子商務平台，平台主要提供帶私域流量的娛樂電子商務，包括提供數字產品及服務。關於賽博幻境（香港）有限公司賽博幻境（香港）有限公司（前稱「智能生產管理系統有限公司」）從事提供人工智能語音服務。 Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月6日 - (亞太商訊 via SeaPRwire.com) - 8月5日，亞洲知名美容護膚集團自然美生物科技有限公司（「自然美」）及其附屬公司（以下簡稱「集團」；香港上市股份代號：00157）今天公布截至2025年6月30日止六個月的中期業績（「回顧期」）。集團上半年營業額增長近70%，突破2.6億港幣，溢利激增136%達1,100萬港幣，多項核心指標創下歷史同期新高，彰顯其在美容護膚領域的強勁發展韌性與增長潛力。作為集團核心市場，中國大陸地區上半年營業額约2.2億港幣，同比增幅高達101%，成為驅動整體業績增長的主要動力。渠道方面，加盟模式表現尤為出色，營業額达2億港幣，同比增長115%；同期新增加盟展店數達237家，增長88%，門店網絡的快速擴張為營業額增長提供了堅實支撐；直營（含專櫃）渠道營業額增長112%，達1,300萬港幣，突顯品牌在終端零售端的精細化運營成效。另外在保健食品板塊之營業額亦增長近110%，為2,800萬港幣，驗證「全健康」戰略成效。自然美生物科技主席兼執行董事雷倩博士表示：「集團『AI 科技、美業、全健康』戰略成效顯著，成功推動品牌升級。在 AI 科技方面，我們通過與西班牙 INDIBA 品牌深度合作，引入其尖端儀器並聯合打造白月光系列產品，借助國際先進技術與自研護膚方案的協同效應，推動該系列成為市場爆款，白月光系列的熱銷正是這一合作模式的最佳見證。上任甫一年的集團行政總裁鄭吉崇帶領團隊在美業生態布局上，引入代理商的展店及合作模式，使加盟渠道高速增長。鄭吉崇表示，我們構建了『標準化運營體系 + 全鏈路支持體系』，讓加盟商能夠快速複製成功模式，今年上半年就有237家新門店順利落地並實現業績增長。除美妝、AI 儀器雙增長外，保健食品的全健康戰略，更是實現了2,800萬港幣營業額、同比增長近110% 的亮眼成績，這其中主要得益於兩點：一是產品緊扣消費者『內外兼養』的健康需求，依托全球採購的優質原料與兩岸研發中心的技術支撐，打造高品質營養方案；二是通過『全健康』場景整合，將保健食品與護膚服務聯動推廣，形成消費閉環，這也印證了市場對我們『護膚 + 健康管理』綜合解決方案的高度認可。」展望未來，受惠於消費回暖和產業升級雙重利好，集團將以「AI科技、美業、全健康」戰略為核心，重點推進兩大方向：持續整合產業鏈資源，加速全渠道數碼化轉型；運用大資料精准洞察需求，打造「需求-研發-管道」閉環體系，鞏固市場領先地位。照片展示:自然美门店關於自然美生物科技有限公司（香港上市股份代號：00157）東森自然美作為中國領先的上市美容護膚品牌，自 1972 年創立以來，始終以「自然就是美」為核心理念，深耕行業 54 年。依托「AI 科技、美業、全健康」戰略驅動，品牌在全球佈局2,000 家門店，成為國人自主創立的跨國生物科技標桿，持續引領美妝護膚行業革新。傳媒聯絡方法：縱橫財經公關顧問有限公司吳燕霞電話：2864 4812電郵：mandy.go@sprg.com.hk張銘伊電話: 2114 4903電郵: maggie.zhang@sprg.com.hk 網站： http://www.sprg.com.hk Copyright 2025 亞太商訊 via SeaPRwire.com.

JAKARTA, Aug 6, 2025 - (ACN Newswire via SeaPRwire.com) - Chinese automotive company SERES and electric vehicle brand AITO launched a road tour from Chongqing to Jakarta on Monday (4/8) to test the brand's durability, as well as celebrate 75 years of Indonesia-China diplomatic relations. The "Open the Way with AITO" road tour will pass through several ASEAN countries on its way to Jakarta, covering a route of 5,000 kilometers. Vehicles on the tour are the AITO M5, AITO M7, and AITO M9.Indonesian Chamber of Commerce and Industry China Committee (KIKT) Chairman Garibaldi 'Boy' Thohir, SERES Automobile President Leon He, and Indonesian Ambassador to China and Mongolia Djauhari Oratmangun at Chongqing-Jakarta AITO Road Tour launch in Chongqing, China on Aug 4."The KIKT (Indonesian Chamber of Commerce and Industry Bilateral Committee for China) is here in Chongqing to launch this major event where AITO vehicles will travel a route from Chongqing, China to Indonesia, with a big welcoming event planned on August 25 in Jakarta," said KIKT Chairman Garibaldi "Boy" Thohir to ANTARA after the launch event in Chongqing on Monday.The road tour, titled "Open the Way with AITO," will pass through several ASEAN countries on its way to Jakarta, covering a route of about 5,000 kilometers. The AITO vehicles in the road tour are the AITO M5, AITO M7, and AITO M9."The Chinese government, especially President Xi Jinping, has promoted 'One Belt One Road,' and this is one example of the Silk Road from Chongqing to Indonesia. With this event, we also hope to attract the attention of young people," Boy added.Young people will be represented in the event by celebrities such as Boy William and Gading Marten, as well as Kanjeng Gusti Pangeran Adipati Arya (KGPAA) Mangkunegara X Bhre Cakrahutomo Wira Sudjiwo, commonly known as Gusti Bhre."Because many young people like fun, informal things, I am involving Boy William and Gading Marten to be icons so that young Indonesians can see how far Chinese technology has progressed, and especially the good relationship between the two countries," Boy explained.The Indonesian Ambassador to China and Mongolia, Djauhari Oratmangun, stated that this event was not only related to Indonesia and China but to several ASEAN countries. "This shows that the NEV (new energy vehicle) industry will enter Indonesia and produce in Indonesia for the ASEAN market, and therefore the Indonesian Embassy in Beijing fully supports it," said Ambassador Djauhari. Ambassador Djauhari sees renewable energy vehicles (New Energy Vehicles) as part of the green economy. "We have the materials, especially for producing batteries as the main component of the electric vehicle industry. Therefore, we welcome the presence of the electric vehicle industry in Indonesia, and China has become one of the world's main producers of electric vehicles," Ambassador Djauhari added.In his remarks, Ambassador Djauhari said that young people, innovators, and even tourists are beginning to play a role in Indonesia-China relations. "Events like this spark a curiosity, a spirit of adventure and mutual understanding. As this tour starts from Chongqing, the hope is that it can also bring about a more integrated ASEAN-China region, a more strategic, sustainable, and comprehensive Indonesia-China partnership, and a stronger, more environmentally friendly future," Ambassador Djauhari explained.SERES Automotive President Leon He said that AITO had previously undertaken a similar overland expedition in Europe. "Last year's expedition covered 15,000 km in 38 days to Paris, which proved the toughness of our vehicles. This year, the journey will continue to Indonesia, a strategic market with an economic potential of 150 billion US dollars and a strong commitment to new energy vehicles," said Leon He.Leon He noted that the presence of the SERES factory in Sokonindo, Indonesia since 2017 has been an important stepping stone for expansion in the ASEAN region. The AITO brand itself has not yet entered Indonesia, but SERES Automobile has been present through PT Sokonindo Automobile, which oversees the DFSK brand.The Sokonindo factory has stood since 2017 in the Modern Cikande Industrial Estate, Serang, Banten, covering 20 hectares, with a total investment of USD 150 million and a maximum production capacity of 50,000 units per year for both domestic and international markets. Indonesian Chamber of Commerce and Industry: https://kadin.id/en/ Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 5, 2025 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK) today announced that the supplemental application for the production expansion of NEFECON® has been officially approved by China’s National Medical Products Administration (NMPA). This approval for production expansion will further boost capacity and increase product supply, enabling a more efficient response to the growing clinical demand in China and across Asia.NEFECON® is the first and only etiological treatment for IgA nephropathy (IgAN) to receive full approval in China, the United States, and Europe, serving as a foundational first-line therapy for patients with IgAN. Since its initial approval in China in November 2023, NEFECON® was subsequently included in the National Reimbursement Drug List (NRDL) in November 2024, and received full approval from the NMPA in May 2025, irrespective of proteinuria levels, benefiting most individuals living with IgAN.NEFECON® specifically modulates the mucosal immune system in the gut to reduce the formation of pathogenic galactose-deficient IgA1 (Gd-IgA1) that trigger IgAN. Results from the Phase 3 clinical study NefIgArd demonstrated that NEFECON® reduces the decline in kidney function by 50%. Results from Phase 3 clinical study NefIgArd of the Chinese population shows that NEFECON® reduces kidney function decline by 66%, and delays disease progression to dialysis or kidney transplantation by 12.8 years.“The expansion of our NEFECON® production capacity will help better meet the growing clinical treatment needs of IgAN patients in China.” Said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “China has one of the highest rates of primary glomerular disease in the world, with more than 5 million patients estimated to be living with IgAN and over 100,000 new cases diagnosed each year. Chinese IgAN patients generally experience faster disease progression and poorer prognosis, highlighting a significant unmet medical need.As the only etiological treatment for IgAN currently recommended by both international and Chinese guidelines, the expansion of NEFECON® production will further accelerate the uptake of etiological treatment, enabling more patients to access standardized treatment earlier to delay disease progression and protect kidney function. We will continue to enhance the accessibility and affordability of NEFECON®, supporting its advancement from ‘changing the treatment landscape’ to ‘redefining the standard of care’.”NEFECON®, as the only in-disease IgAN treatment has been included in the KDIGO 2024 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV) (public review draft), making it the only targeted therapy endorsed by both international and Chinese guidelines. NEFECON® has been approved across all Everest Medicines’ territories, including mainland China, Hong Kong SAR, Macau SAR, Taiwan region, China, as well as Singapore and South Korea, and continues to expand its therapeutic impact across Asia.As production capacity continues to grow and supply capabilities improve, NEFECON® is well positioned to benefit a broader patient population by accelerating the uptake of etiological treatment, enabling more patients to access standardized care earlier to delay disease progression and preserve kidney function. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 5, 2025 - (ACN Newswire via SeaPRwire.com) - On August 4, the China Robotics Industry ETF (159551) rose by 2.44%, as investor enthusiasm for the sector continues to surge. Humanoid robotics is transitioning from a phase of “technical breakthroughs” to one of “scenario implementation,” marking the start of a new acceleration cycle. With a series of industry catalysts unfolding, the robotics segment in the Hong Kong market is entering a structural upswing.Among the emerging opportunities, Shoucheng Holdings (0697.HK) stands out as a rare asset platform company with full-chain industrial deployment and real scenario execution capability.1. From Showroom to Deployment: Humanoid Robots Hit the Ground RunningAt the 2025 World Artificial Intelligence Conference (WAIC) held in late July, over 150 humanoid robots were demonstrated performing real-time dynamic tasks across industrial, service, and medical settings — a first in China. Unlike previous static displays, this year’s event showcased robots in real application scenarios such as cleaning, concierge services, and logistics handling, demonstrating the rapid convergence of hardware, algorithms, and computing power.At the same time, major news continues to drive investor sentiment:Unitree Robotics has entered IPO counseling, and the World Robot Conference 2025 is set to launch with over 100 new product debuts.In this context, Shoucheng Holdings stands out as a rare Hong Kong-listed company with both industrial integration capabilities and operational execution power, filling a critical gap in the market.2. From Conference to Application: Shoucheng’s Robot Ecosystem Comes AliveWhile many firms are still stuck in the “capital narrative” stage, Shoucheng Holdings is entering a phase of real industrial depth, evolving from investor to industrial connector and platform enabler.At the upcoming World Robot Conference 2025, Shoucheng is organizing an official sub-forum titled “Robotics Investment and Innovation Forum”, bringing together top-tier founders and venture capitalists to discuss commercialization strategies for humanoid robotics in the so-called “mass production year.” The forum serves as a bridge linking capital, technology, and market demand.In parallel, at the World Humanoid Robot Games, Shoucheng’s subsidiary Beijing Robotics Leasing Co. has provided 78 robots from its portfolio companies — including Booster Robotics, Galaxea-AI, Noetix Robotics, and Galbot — to support training in core competition categories such as football, athletics, and scene-based tasks. Several invested companies are also participating directly, enabling a full cycle of product testing, feedback, and application validation.Shoucheng’s ability to integrate investment, leasing, agency services, and operations has led to the creation of a scalable and repeatable robotics application infrastructure, positioning it as one of the few platform companies in the Hong Kong market with true industrial depth.3. A Rare Valuation Opportunity in Hong Kong’s Robotics MarketWhile many companies in China’s robotics ecosystem are either unlisted or trading at high valuations, Shoucheng Holdings currently trades at just around HK$1.90 and has completed multiple rounds of share buybacks. This signals strong management confidence in the company’s long-term value.In a market that favors “high growth + application-driven” assets, Shoucheng — with its triple focus on robotics, REITs, and medical technology — is emerging as one of the most compelling industrial platforms for investors riding the next robotics wave.Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 ACN Newswire via SeaPRwire.com.

PHILADELPHIA, PA, Aug 6, 2025 - (ACN Newswire via SeaPRwire.com) - TruMerit, a worldwide leader in international credentials evaluation to support health worker careers, today introduced the Certified Global Nurse (CGN), the world's first truly global credential for first-level, general nurses (RNs).TruMerit | Global careers. Care anywhere.The new, merit-based credential is available to any qualified nurse - from any country - to recognize their competencies, regardless of where they choose to live and work. It is awarded upon passage of TruMerit's Nurse Qualifying Exam (NQE), which applicants may take after verification of their nursing education and licensure.Previously known as the CGFNS Qualifying Exam and used by nurses migrating to the United States, the NQE was reinvented with a global focus to support the ongoing evolution of nursing practice worldwide and particularly the emergence of key challenges such as digital health, mental health, and climate change. This was achieved through a collaborative process involving more than 70 nursing experts from 50 countries, with all World Health Organization regions and World Bank country income levels represented. The experts agreed upon a core set of nursing practice standards after analyzing nursing competency frameworks from 37 countries.In addition to its role as a key requirement for the CGN credential, the upgraded exam continues to support other TruMerit programs - such as the VisaScreen® Visa Credentials Assessment Service and the Certification Program® - as a shared global framework for validating the applied knowledge and practice competence of nurses worldwide."The Certified Global Nurse credential offers nurses everywhere a common framework for meeting globally agreed-upon essential nursing practice standards," said Dr. Peter Preziosi, TruMerit's President and CEO. "When nurses carry the credential, their employers and colleagues will know that their applied nursing knowledge and skills are validated against a global benchmark, attesting to their qualifications for delivering quality healthcare."The credential is ultimately intended to provide nurses with greater mobility within the profession, within their native countries, and across geopolitical boundaries throughout their careers."By signifying work-readiness on an international scale, and thereby helping expand the pool of readily identifiable qualified nurses worldwide, global credentialing will become part of the solution to the challenges health systems are facing around the world," said Preziosi."We hope this credential can contribute to a sustained, collaborative effort involving many stakeholders-health ministries, international agencies, health systems, nursing schools, and nursing associations worldwide-to harmonize nursing education and practice and support the future growth of the global nursing workforce," he said.The Nurse Qualifying Exam is a proctored examination that will be offered four times a year at more than 1,000 Kryterion testing centers located around the world, with the first test window scheduled for November 10-14, 2025. Nurses who wish to earn a CGN credential and sit for the NQE in November must apply by September 30 at the TruMerit website, where they will find more information on the credential and how to prepare for the exam.The testing schedule for 2026 will be announced later this year.About TruMeritTruMerit is a worldwide leader in healthcare workforce development. Formerly known as CGFNS International, the organization has a nearly 50-year history supporting the career mobility of nurses and other healthcare workers - and those who license and hire them - by validating their education, skills, and experience as they seek authorization to practice in the United States and other countries. As TruMerit, this mission has been expanded to building workforce capacity that meets the needs of people in a rapidly evolving global health landscape. Through its Global Health Workforce Development Institute, the organization is advancing evidence-based research, thought leadership, and advocacy in support of healthcare workforce development solutions, including globally recognized practice standards and certifications that will enhance career pathways for healthcare workers. www.trumerit.orgContact InformationDavid St. Johndstjohn@trumerit.orgSOURCE: TruMerit Copyright 2025 ACN Newswire via SeaPRwire.com.

2025年8月6日 - (亞太商訊 via SeaPRwire.com) - 8月4日，範式集團與海博思創簽署合作協議，雙方出資成立合資公司，業務覆蓋「AI+儲能」領域。這一合作標誌著AI在能源存儲的深度應用邁出關鍵一步，將為構建更智能、高效、安全的能源體系註入強大動力。在範式集團創始人戴文淵與海博思創創始人、董事長、首席執行官張劍輝的見證下，範式集團首席財務官劉楠與海博思創董事會秘書、首席財務官高書清代表雙方公司簽署合作協議，為雙方未來的深度合作寫下註解。範式集團聯合創始人、首席研究科學家陳雨強與海博思創技術總裁楊洸等雙方管理團隊共同見證了這一重要時刻。AI賦能 範式集團驅動儲能智慧升級作為核心技術引擎，範式集團將其在人工智能領域的前沿積累全面註入新公司：依托範式領先的AI Agent+世界模型能力，賦予儲能系統前所未有的「智慧大腦」。電力市場AI解決方案能夠實時預測電網供需兩端的波動，結合儲能自身的技術特點，動態優化儲能場站的充放策略，提升效率的同時，達到經濟收益最大化。與此同時，範式集團在能源行業的智能化應用已然擁有豐富的實踐經驗，相關技術也已經成功應用於負荷預測、電網優化、虛擬電廠等場景。此次合作將把其在能源領域特有的AI洞察力與海博思創的儲能硬件深度融合，實現從「感知」到「決策」再到「執行」的閉環智能管理。堅實底座 海博思創鑄就儲能卓越基石依托儲能系統研發、生產及全生命周期管理領域的技術實踐，海博思創將成為合資公司的堅實後盾，提供其在儲能系統全鏈條的頂尖能力：儲能作為AI賦能能源革命的核心應用場景，具有重要的戰略意義。海博思創以AI技術作為創新驅動力，依托研發、製造、運維、運營、交易等維度的海量數據基礎，構建了基於AI算法的儲能場景應用平臺，實現了儲能系統全生命周期的智能化運維管理，有力地推動了企業向綜合能源服務商的轉型升級。AI+儲能 引領智慧能源革命範式集團與海博思創戰略攜手，絕非簡單的技術疊加，而是通過深度協同，解決製約儲能大規模發展的核心挑戰：海博思創創始人、董事長、首席執行官張劍輝在簽約儀式上表示：「在全球能源格局重塑的當下，AI技術正成為推動能源變革的關鍵變量。海博思創與範式集團分別是儲能與人工智能領域的領軍者。兩家公司的理念高度契合，通過此次合作，我們將實現儲能技術與AI算法的深度融合，達到1+1>2的協同效應」。提及「AI+儲能」，範式集團創始人戴文淵表示，新能源產業空間廣闊，但天然波動性與系統復雜性正成為發展瓶頸。破解之道就在於雙核驅動：儲能構築能源流轉的物理基石，AI打造智能決策的數字中樞--前者穩定「波峰波谷」，後者優化「發-輸-配-用」全鏈條效率。今天，範式集團與海博思創強強聯合，將在「AI+儲能」領域占有一席之地，創造出高於現有數十倍的產值。範式集團與海博思創的合作，將是儲能產業走向數智化的關鍵一步。當頂尖AI大腦與強健儲能軀幹完美結合，製約儲能大規模發展的種種挑戰都被解決，「AI+儲能」將釋放其前所未有的潛力，共同推動全球能源轉型進程。 Copyright 2025 亞太商訊 via SeaPRwire.com.

2025年8月5日 - (亞太商訊 via SeaPRwire.com) - 8月4日，機器人產業ETF（159551）上漲2.44%，板塊熱度持續攀升。人形機器人產業正由「技術爆點」進入「場景兌現」的加速期。隨着一系列產業事件密集釋放，港股市場上的機器人板塊迎來新一輪結構性行情。其中，最值得市場關注的標的之一，是已完成產業鏈全佈局、具備平台屬性的資產型公司--首程控股（0697.HK）。一、 行業催化不斷，人形機器人從展台走進應用場景於7月底舉行的2025世界人工智能大會（WAIC）上，首次實現超過150台人形機器人同步進行動態任務展示，涵蓋工業、服務、醫療等多個場景，成為繼AIGC後人工智能應用最具想像空間的方向。與以往靜態展示不同，今屆展會首次實現任務級應用，機器人在清潔、接待、搬運等環節展現擬人化操作，象徵着「硬件+算法+算力」的產業協同模式正加速成熟。與此同時，Unitree Robotics（宇樹科技）啟動上市輔導，世界機器人大會即將開幕等消息密集釋放，強化整體板塊情緒，也讓產業鏈上的優質公司獲得更多關注。而在港股市場中，真正擁有產業落地能力、深度參與核心企業實操，並能貫通「投資+運營」鏈條的公司仍屬稀缺，首程控股正好填補了這一空白。二、 從大會到應用，首程控股打通機器人產業「場景通路」與眾多仍停留在「資本故事」階段的企業不同，首程控股的機器人戰略已進入深水區，角色正從投資人轉為產業連結者與應用推動者。在行業影響層面，首程控股主辦了即將舉行的2025世界機器人大會官方分論壇--「機器人行業創投主題交流會」，聚焦「量產元年」背景下的投資邏輯與落地路徑，吸引數十位頭部機器人企業創始人與投資機構參與，成為連結技術、資本與需求的重要橋樑。在應用實踐層面，於同期舉行的世界人形機器人運動會中，首程控股旗下北京機器人租賃公司為賽事訓練提供了來自Booster Robotics（加速進化）、Galbot（銀河通用）、Noetix Robotics（松延動力）與Galaxea-AI（星海圖）等企業的78台設備，涵蓋足球、田徑、酒店服務等多項核心應用場景，多家被投企業亦親自參與比賽，完成從技術驗證到應用落地的完整閉環。在平台協同層面，首程控股已構建起涵蓋投資、租賃、代理、運營的產業架構，打通研發、測試、交付、訓練、反饋的全流程，成為港股市場中極少數真正具備產業穿透力的平台型企業。三、港股稀缺估值窪地，產業穿透力打開重估空間在目前國內機器人產業鏈進入上行週期的背景下，大量企業仍處於估值高位或尚未上市階段。而在港股市場，擁有真實運營能力、估值處於低位、產業兌現節奏加快的標的極為稀缺。目前首程控股股價仍位於1.9港元附近，已完成多輪股份回購，管理層以真金白銀釋放對公司中長期價值的高度認可。在市場對「高成長+場景兌現」型資產偏好不減的背景下，擁有「機器人 + REITs + 醫療健康」三重資產組合的首程控股，有望成為本輪機器人行情中最具產業想像力的港股平台。Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 亞太商訊 via SeaPRwire.com.

佛羅裡達州博卡拉頓, 2025年8月5日 - (亞太商訊 via SeaPRwire.com) - Atlas Lithium Corporation（納斯達克股票代碼：ATLX）（「Atlas Lithium」或「公司」），一家領先的鋰開發公司，很高興宣布 SGS Canada Inc.（「SGS」）已完成公司百分之百持有的 Neves 鋰項目（「項目」）的最終可行性研究（「DFS」），這是一份依據美國《Regulation S-K》第 1300 項（「Regulation S-K 1300」）準則所編製的技術報告。這個硬岩項目非常適合作為低成本的露天採礦作業，因為其鋰輝石礦床相對靠近地表。該項目位於巴西米納斯吉拉斯州，涵蓋 Atlas Lithium 擁有的 98 項鋰礦權中的 4 項。根據 DFS 的詳細資料，Neves 項目預計將帶來強勁的財務指標，內部報酬率（「IRR」）為 145%，自開始營運起 11 個月內回本，稅後淨現值（「NPV」）為 5.39 億美元。值得注意的是，DFS 預估 Neves 項目的營運生產成本僅為每公噸 489 美元鋰精礦，使 Atlas Lithium 成為全球成本最低的生產商之一。這些指標的完整細節已包含於 DFS 中，並作為公司截至 2025 年 6 月 30 日季度財報（Form 10-Q）所附的文件，提交至美國證券交易委員會。Marc-Antoine Laporte 為 DFS 根據 Regulation S-K 1300 所認定的合格人員，來自 SGS——一家在礦產項目測試、檢驗與認證服務方面享有盛譽的全球領導企業。業界領先的資本效率與低營運成本DFS 報告指出，該項目預計所需的直接資本支出為 5,760 萬美元，遠低於巴西其他已公告項目的資本成本。值得注意的是，Atlas Lithium 先前已投入約 3,000 萬美元，用於購置及運輸項目中新製造的致密介質分離（DMS）工廠至巴西。公司已取得兩筆非稀釋性預付款協議，合計 4,000 萬美元鋰精礦銷售額，並獲得其他方的額外資金意向，包括十年期債務融資選項，這些皆可支持項目的資本需求。公司認為，DFS 驗證了該項目強勁的經濟效益，使其成為全球資本效率最高且硬岩鋰礦開發成本最低的項目之一。該項目將採用已驗證的 DMS 技術，全面的冶金測試顯示預期鋰回收率達 61.7%，能生產高品質、低雜質的鋰精礦。此相對簡單且低風險的 DMS 處理方法，最大限度地降低了技術複雜性與營運風險，同時實現低環境影響。Atlas Lithium 擁有的礦權，詳見 DFS 報告，已於 2025 年 5 月 27 日獲得巴西礦業暨能源部頒發「Portaria de Lavra」（採礦許可證）資格——這是巴西最高層級的礦權所有權，允許持續進行採礦作業。項目內多個礦床區域沿走向與深度仍有資源擴展空間，預計將延長礦山壽命。此外，項目礦權範圍內仍有多處高潛力地質目標，為未來勘探提供誘人機會。本項目位於被稱為「鋰谷」的 Vale do Jequitinhonha 中已發展完善的 Araçuaí 斑岩區，享有便利的基礎建設，包括鄰近交通網絡、水源與技術熟練的勞動力。該項目符合由巴西整合與區域發展部頒布的東北部發展總署（SUDENE）稅收優惠，企業所得稅率將從 34% 降至 15.25%，進一步提升獲利能力。Atlas Lithium 董事長兼執行長 Marc Fogassa 表示：「DFS 顯示，我們最初聚焦開發一個低資本需求、短期內可獲利的鋰生產資產的願景，可能帶來卓越的回報。低資本強度與快速回本期的組合，預期將為股東創造非凡價值，並使 Atlas Lithium 得以受惠於 Neves 項目及我們擁有的其他高潛力鋰礦區未來的有機擴展機會。更重要的是，我們在 Vale do Jequitinhonha 地區創造了大量優質就業機會，展現本項目對社會的重大貢獻。」資深領導團隊推動項目執行在與 SGS 共同完成最終可行性研究（DFS）後，Atlas Lithium 的項目管理主管暨工程副總裁 Eduardo Queiroz 先生負責監督項目執行工作。Queiroz 先生擁有超過二十年的豐富經驗，專注於管理複雜且大型的採礦項目。Queiroz 先生表示：「DFS 展現了本項目的技術穩健性，採用經 SGS 這家鋰產業頂尖公司驗證的成熟致密介質分離（DMS）技術與全面的冶金測試成果。隨著我們的加工廠已完全建造且資金到位，且現有 DFS 報告，我們已系統性降低了項目風險。我很榮幸能領導 Atlas Lithium 成為鋰生產商之旅的執行階段。」Salinas 與 Clear：下一個擴展前沿Atlas Lithium 戰略性地布局於巴西廣泛的區域鋰礦勘探組合，特別是通過推進公司百分之百持有的 Salinas 項目與 Clear 項目。Atlas Lithium 的 Salinas 項目距離先前由 Latin Resources 持有的 Colina 鋰資產僅 5 英里，該資產是 Pilbara Minerals 於 2024 年以約 3.7 億美元收購 Latin Resources 的主要原因之一。在 Salinas 項目中，Atlas Lithium 已取得有希望的初步成果，包括發現極靠近地表的富鋰輝石斑岩，以及土壤地球化學和 LIDAR 地質測繪的高度正面結果。Atlas Lithium 的 Clear 項目距離 Sigma Lithium 正在營運的鋰礦不足 4 英里，展現重大未開發潛力，並同樣從土壤地球化學及 LIDAR 地質測繪中獲得非常正面的結果。關鍵礦產多元化布局Atlas Lithium 亦持有 Atlas Critical Minerals Corporation（OTCQB: JUPGF）約 30% 股權，該公司另行從事鈾、稀土、鈦和石墨的勘探計畫。關於 Atlas Lithium CorporationAtlas Lithium Corporation（納斯達克代碼：ATLX）是一家專注於推動 Neves 項目生產化的鋰開發公司。Neves 項目的最終可行性研究顯示卓越的經濟效益，內部報酬率達 145%、淨現值 5.39 億美元，且回本期僅 11 個月。Neves 項目已獲得營運許可，其致密介質分離工廠亦已購置並運抵巴西。Atlas Lithium 擁有約 539 平方公里的鋰礦權，為巴西上市公司中鋰礦勘探面積最大的公司。此外，Atlas Lithium 目前持有 Atlas Critical Minerals Corporation（OTCQB: JUPGF）約 30% 股權。安全港聲明本新聞稿包含《1933年證券法》第27A條及《1934年證券交易法》第21E條所定義之前瞻性陳述。前瞻性陳述係基於Atlas Lithium及其子公司當前計劃、估算與預測，且受固有風險與不確定因素影響，實際結果可能與前瞻性陳述有所不同。此類陳述包括但不限於市場及產業細分成長、需求及新舊產品接受度；生產、儲量、銷售、盈餘、收入、利潤率或其他財務項目之任何預測；管理層對未來營運之計劃、策略及目標；未來經濟狀況或績效之任何陳述；在巴西經營業務之不確定性；以及對未來事件之所有假設、期望、預測、意圖或信念。因此，投資者不應對此類前瞻性陳述過度依賴。實際結果可能因以下因素（含但不限於）與前瞻性陳述有所差異：Atlas Lithium 成功組裝及啟動其模組化工廠的能力；Neves 鋰項目依最終可行性研究（DFS）報告達成預估產量、開發計劃及成本估算；實際與估計礦產儲量及資源、實際與估計開發及營運成本、估計與實際產量之差異；持續進行的岩土技術分析結果；巴西之營商環境；整體經濟狀況、地緣政治事件及法規變更；資金可得性；Atlas Lithium 維持競爭地位之能力；空頭操控股價的行為；及對核心管理團隊的依賴。公司及其子公司相關其他風險詳述於公司於2025年3月28日向美國證券交易委員會（SEC）提交之Form 10-K「風險因素」章節，以及2025年8月4日提交之Form 10-Q中。亦請參閱公司於SEC所提交的其他文件，均可於 www.sec.gov 查閱。此外，任何前瞻性陳述僅代表公司當前之觀點，且不應視為代表其後續任何日期之觀點。公司明確否認有義務更新任何前瞻性陳述。投資人關係Gary Guyton投資人關係副總裁+1 (833) 661-7900gary.guyton@atlas-lithium.comhttps://www.atlas-lithium.com/@Atlas_Lithium Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月5日 - (亞太商訊 via SeaPRwire.com) - 今日，雲頂新耀（HKEX: 1952.HK）宣布旗下中國首個且唯一獲得完全批准的IgA腎病對因治療藥物耐賦康®（布地奈德腸溶膠囊）擴產補充申請已正式獲得中國國家藥品監督管理局（NMPA）批准，標志著該產品在中國市場的供應能力將實現進一步提升。此次擴產獲批將進一步提升產能，增加產品供應，更高效地響應中國及亞洲地區對耐賦康®的持續增長的臨床需求。為更多IgA腎病患者提供及時、創新的治療選擇。作為全球首個且目前唯一在中國、美國和歐洲獲得完全批准的IgA腎病對因治療藥物，自2023年11月在中國獲批以來，耐賦康®迅速確立了其作為IgA腎病一線治療的基石地位，並於2024年11月被納入國家醫保目錄。2025年5月，該藥品進一步獲得NMPA完全批准，適應症不再受限於蛋白尿水平，顯著擴大了適用患者群體。據悉，耐賦康®通過特異性調節腸道黏膜免疫，減少誘發IgA腎病的半乳糖缺陷的IgA1（Gd-IgA1）產生，從而阻止下遊的病理途徑，最終有效控制蛋白尿並保護腎功能。在全球III期NefIgArd研究中，耐賦康®能使腎功能下降風險降低50%，中國人群數據分析顯示，能減少66%腎功能下降，疾病進展至透析或腎移植的時間延緩12.8年。雲頂新耀首席執行官羅永慶表示：「本次產品生產產能的提高，將更好滿足亞洲地區IgA腎病患者日益增長的臨床治療需求。IgA腎病在亞洲高發，其中中國是全球原發性腎小球疾病發病率最高的國家之一，估計目前有超過500萬名IgA腎病患者，每年新增確診患者超過10萬例。中國IgA腎病患者的疾病進展快、預後差，臨床尚存在巨大未滿足的治療需求。作為目前唯一獲國內外指南共同推薦的IgA腎病對因治療藥物，耐賦康®的擴產將加速對因治療的普及，助力更多患者盡早開啟規範治療、延緩疾病進展、保護腎功能。我們也將持續推動耐賦康®的可及性與可負擔性，加速其從『改變治療格局』邁向『重塑治療標准』。」憑借創新的作用機制和突出的臨床優勢，耐賦康®先後被納入《2024版KDIGO IgA腎病和IgA血管炎臨床管理實踐指南（公開審查版）》以及《中國成人IgA腎病及IgA血管炎臨床實踐指南（預審版本）》，成為目前唯一同時獲國際與國內指南推薦的IgA腎病對因治療藥物。這不僅改變了傳統的IgA腎病治療方案，對因治療和支持治療需同時進行，並確立了耐賦康®作為IgA腎病一線治療的基石地位。目前，耐賦康®已在雲頂新耀所有授權區域（包括中國大陸、中國香港、中國澳門、中國台灣、新加坡及韓國）獲得批准,在亞洲地區持續拓展其治療影響力。隨著產能的持續擴張和市場供應能力的增強，耐賦康®有望造福更多患者，推動IgA腎病治療邁入精准治療新階段。 Copyright 2025 亞太商訊 via SeaPRwire.com.

NEW YORK, Aug 4, 2025 - (ACN Newswire via SeaPRwire.com) - Traveler Care, a breakthrough medical dispatch platform that brings urgent care directly to travelers in hotels, Airbnbs, and vacation rentals, has officially launched worldwide - offering travel insurance companies a high-impact solution to reduce avoidable emergency room and hospital claims.Traveler care traveler.care home pageA Concierge Alternative to the Emergency RoomTraveler Care connects travel insurers and their policyholders to a network of licensed, on-call providers who visit travelers in their accommodations - typically within 60-90 minutes. Conditions such as flu, food poisoning, dehydration, allergic reactions, UTIs, sprains, and wound care are treated on-site, eliminating the need for an ER visit."In most cases, travelers just need a doctor - not a hospital admission," said Eli Ofel, founder of Traveler Care. "We've built a scalable, insurer-ready solution that saves money and delivers a far better traveler experience."Reduce Claims by $10,000+ Per VisitOn average, a non-emergency ER visit costs travel insurers $13,000 to $17,000. Traveler Care treats the same conditions in-room for $1,700 to $3,000 - including diagnostics like mobile X-ray, ultrasound, IV therapy, and wound treatment.Pilot results have shown:- 83% reduction in ER claim volume- $10,000+ savings per case avoided- Higher satisfaction scores among travelersBuilt for Travel Insurance PartnersTraveler Care is fully designed for insurance integration - with white-label and API options available for TPAs, underwriters, and global assistance networks.Platform features:- Nationwide U.S. coverage (with international expansion underway)- A robust dispatch network, for example companies like Leaa Health, Sickday, Heal, DocGo and more, any location that the travel insurance is experiencing high volume travel care will create a solution for that particular location within 60 days.- HIPAA-compliant documentation + one-click claims integration- Supports care delivery to hotels, Airbnbs, resorts, and serviced apartmentsNow Onboarding Insurance Companies Worldwide"We believe travel insurance companies shouldn't just pay for care - they should deliver it smarter," said Ofel. "With Traveler Care, you lower claims without compromising care."Insurance providers, TPAs, and global assistance companies are invited to partner and deploy in-room urgent care as part of their medical benefit stack.ContactTo schedule a private demo or receive our ROI case study:Visit www.traveler.careEmail: partners@traveler.carePhone: +1 (347) 733-0563About Eli OfelEli Ofel is a serial entrepreneur and visionary behind multiple AI- and tech-powered platforms in healthcare, finance, and transportation. He is the founder and CEO of Traveler Care, Run.Vet, Leaa Health, 02.Market, and Lender.Market. With over 20 years of experience in healthcare operations, insurance workflows, and mobile logistics, Ofel brings a proven ability to bridge patient needs with scalable platform solutions - saving time, money, and lives.Contact InformationEli OfelCEOeli@traveler.care3477330563SOURCE: Traveler care Copyright 2025 ACN Newswire via SeaPRwire.com.

Boca Raton, Florida--(ACN Newswire via SeaPRwire.com - August 4, 2025) - Atlas Lithium Corporation (NASDAQ: ATLX) ("Atlas Lithium" or "Company"), a leading lithium development company, is pleased to announce that SGS Canada Inc. ("SGS") has completed the Definitive Feasibility Study ("DFS") for the Company's 100%-owned Neves Lithium Project ("Project"), a technical report prepared under the U.S. guidelines of Item 1300 of Regulation S-K ("Regulation S-K 1300"). This hard-rock Project is well-suited to being a low-cost open-pit mining operation, as its spodumene deposits are located relatively close to the surface. Located in the state of Minas Gerais, Brazil, the Project encompasses 4 of the 98 mineral rights for lithium owned by Atlas Lithium. As detailed in the DFS, the Neves Project is expected to deliver strong financial metrics with an internal rate of return ("IRR") of 145%, payback in 11 months from the start of operations, and an after-tax net present value ("NPV") of $539 million. Importantly, the DFS estimates the Neves Project to have operational production costs of only $489 per tonne of lithium concentrate, positioning Atlas Lithium among the world's lowest-cost producers. Complete details of these metrics can be found in the DFS, filed with the Securities and Exchange Commission as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025. Marc-Antoine Laporte from SGS serves as the Qualified Person for the DFS under Regulation S-K 1300. SGS is well-known as a global leader in testing, inspection, and certification services for mineral properties and projects.Industry-Leading Capital Efficiency and Low Operating CostsThe DFS supports that expected direct capital expenditures of $57.6 million will be needed for the implementation of the Project, by far the lowest such capital costs among other announced projects in Brazil. Notably, Atlas Lithium has already invested approximately $30 million in acquiring and transporting the Project's newly fabricated dense media separation ("DMS") plant to Brazil, as previously reported. The Company has secured two non-dilutive pre-payment agreements for its lithium concentrate totaling $40 million and has received additional funding interest from other parties, including 10-year debt financing options, any of which could support the Project's capital requirements.The Company believes that the DFS validates the Project's strong economics, positioning it among the most capital-efficient and lowest-cost hard-rock lithium developments globally. The Project will employ proven DMS technology, with comprehensive metallurgical testing demonstrating an expected robust lithium recovery rate of 61.7% to produce high-quality, low-impurity lithium concentrate. This relatively straightforward, low-risk DMS processing methodology minimizes technical complexity and operational risk while enabling a low environmental footprint.Atlas Lithium's mineral right to be mined, as detailed in the DFS, received its "Portaria de Lavra" (mining concession) status from Brazil's Ministry of Mines and Energy on May 27, 2025 — the highest level of titleship in Brazil and one that allows continuous mining operations. Multiple deposit areas within the Project remain open for resource expansion along strike and at depth and are thus expected to extend the life of mine. Additionally, numerous high-potential geological targets remain within the Project's mineral rights, providing compelling opportunities for future exploration.Located in the established Araçuaí Pegmatite District in the Vale do Jequitinhonha, often called Lithium Valley, the Project benefits from favorable infrastructure, including proximity to transportation networks, water resources, and skilled labor. The Project qualifies for tax incentives from the Superintendency for the Development of the Northeast (SUDENE), as promulgated by Brazil's Ministry of Integration and Regional Development, reducing the corporate tax rate from 34% to 15.25% and further enhancing profitability."The DFS indicates potentially outstanding returns for our initial vision of developing a focused, near-term, profitable lithium production asset with minimal capital requirements," said Marc Fogassa, Chairman and CEO of Atlas Lithium. "The combination of our low capital intensity and rapid payback period is expected to create exceptional value for our shareholders while positioning Atlas Lithium to benefit from future organic expansion opportunities at Neves and other high-potential lithium areas that we own. Importantly, we are creating many quality employment opportunities in the Vale do Jequitinhonha region, representing a significant societal contribution of our Project."Experienced Leadership Driving Project ImplementationFollowing his leadership role in collaborating with SGS on the DFS, project implementation activities are being supervised by Eduardo Queiroz, Atlas Lithium's Project Management Officer (PMO) and Vice President of Engineering. Mr. Queiroz has more than two decades of hands-on experience managing complex, large-scale mining projects."The DFS demonstrates the technical robustness of the Project, with proven DMS technology and comprehensive metallurgical test work validated by SGS, a premier firm in the lithium space," said Mr. Queiroz. "With our processing plant fully fabricated and paid for, and now with the DFS in hand, we have systematically de-risked the Project. I am excited to lead the implementation phase of Atlas Lithium's journey to becoming a lithium producer."Salinas and Clear: The Next Expansion FrontierAtlas Lithium is strategically positioned to capitalize on its extensive regional lithium exploration portfolio in Brazil, particularly through advancement of its Salinas Project and Clear Project, both 100% owned by the Company. Atlas Lithium's Salinas Project is just 5 miles east of the Colina lithium asset previously owned by Latin Resources — a major factor in Pilbara Minerals's acquisition of that company in 2024 for approximately $370 million. At the Salinas Project, Atlas Lithium has already achieved promising initial results, including the discovery of spodumene-rich pegmatites very close to the surface, and highly positive results from soil geochemistry and from LIDAR geological mapping.Atlas Lithium's Clear Project is located less than 4 miles from Sigma Lithium's operating lithium mine, and represents significant untapped potential with highly positive results from soil geochemistry and from LIDAR geological mapping.Diversification in Critical MineralsAtlas Lithium also owns approximately 30% of Atlas Critical Minerals Corporation (OTCQB: JUPGF), a separate company with exploration programs in uranium, rare earths, titanium, and graphite.About Atlas Lithium Corporation Atlas Lithium Corporation (NASDAQ: ATLX) is a lithium development company focused on advancing its Neves Project to production. The Neves Project's Definitive Feasibility Study demonstrates excellent economics with a 145% IRR, $539 million NPV, and an 11-month payback. The Neves Project has received operational permitting, and its dense media separation plant has been acquired and transported to Brazil. With approximately 539 square kilometers of lithium mineral rights, Atlas Lithium owns the largest lithium exploration footprint in Brazil among publicly listed companies. Additionally, Atlas Lithium currently holds an approximate 30% ownership stake in Atlas Critical Minerals Corporation (OTCQB: JUPGF).Safe Harbor StatementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based upon the current plans, estimates and projections of Atlas Lithium and its subsidiaries and are subject to inherent risks and uncertainties which could cause actual results to differ from the forward-looking statements. Such statements include, among others, those concerning market and industry segment growth and demand and acceptance of new and existing products; any projections of production, reserves, sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements regarding future economic conditions or performance; uncertainties related to conducting business in Brazil, as well as all assumptions, expectations, predictions, intentions or beliefs about future events. Therefore, you should not place undue reliance on these forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: Atlas Lithium's ability to successfully assemble and begin operations of its modular plant; reaching estimated production, development plans and cost estimates for the Neves Lithium Project as reported in the Definitive Feasibility Study (the "DFS"); discrepancies between actual and estimated mineral reserves and mineral resources, between actual and estimated development and operating costs, and between estimated and actual production; results from ongoing geotechnical analysis of projects; business conditions in Brazil; general economic conditions, geopolitical events, and regulatory changes; availability of capital; Atlas Lithium's ability to maintain its competitive position; manipulative attempts by short sellers to drive down our stock price; and dependence on key management.Additional risks related to the Company and its subsidiaries are more fully discussed in the section entitled "Risk Factors" in the Company's Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 28, 2025, and in the Company's Form 10-Q filed with the SEC on August 4, 2025. Please also refer to the Company's other filings with the SEC, all of which are available at www.sec.gov. In addition, any forward-looking statements represent the Company's views only as of today and should not be relied upon as representing its views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements.Investor RelationsGary GuytonVice President, Investor Relations+1 (833) 661-7900 gary.guyton@atlas-lithium.comhttps://www.atlas-lithium.com/@Atlas_LithiumTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/261106 Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年8月4日 - (亞太商訊 via SeaPRwire.com) - 持有花園道三號及朗豪坊物業的冠君產業信託（股份代號：2778），於8月1日成功舉辦「ESG Gala」壓軸活動--青少年電影放映會及職業生涯分享會。本屆「ESG Gala」活動以「創新．啟發．融合」為主題，透過一系列專題分享、互動體驗以及藝術展覽，吸引逾千名青年及業界人士參與，展現信託秉持綠色營運與共融理念，推動價值共創，實踐多贏局面。信託積極響應香港政府「共創明『Teen』計劃」，致力支援來自弱勢社群家庭青少年的身心發展，啟發他們探索更廣闊的未來發展方向。作為本屆「ESG Gala」的壓軸活動，信託在朗豪坊Gala Cinema包場舉辦電影放映會，邀請約160名青少年學員及來自18間大型企業的義務友師們，一同欣賞動畫電影，現場充滿歡樂與感動。放映會後，信託特別邀請本地知名動畫師崔氏兄弟與在場青少年分享職涯規劃，引領青少年勇於追夢，探索多元發展方向，促進社會向上流動。冠君產業信託行政總裁侯迅女士表示：「我們很高興與一眾青少年聚首一堂，希望今天的活動及分享能夠啟發青少年，勇敢嘗試、探索、發掘更多的可能性。未來屬於年輕一代，而我們致力成為連接夢想與機遇的平台，與青年同行，共同成長。」本地動畫師崔氏兄弟表示：「很榮幸能夠與青少年分享動畫創作及職涯經驗。我們相信，只要保持好奇心和堅定信念，勇於嘗試，每位年輕人都能找到屬於自己的舞台，開創無限未來。」信託連續三年舉辦ESG主題活動，吸引來自學界、商界、社福界的持份者積極參與與交流，累計參與人次突破50,000，有效加快整個價值鏈的轉型步伐，進一步擴大可持續發展的正面效益。圖片說明：冠君產業信託於 ESG Gala 壓軸舉辦電影放映會，免費邀請約160名共創明「Teen」青少年學員和義務友師一同欣賞動畫電影。本地知名動畫師崔氏兄弟於放映會後與青少年互動，鼓勵年輕人勇敢追夢，探索多元未來。政府共創明「Teen」的學員，包括多元族裔青少年，於朗豪坊參與電影放映會。關於冠君產業信託（股份代號：2778）冠君產業信託擁有及投資提供租金收入的寫字樓及零售物業。信託主要投資位於優越地點的甲級商用物業。現時擁有花園道三號及朗豪坊兩幢位於香港的地標性物業，並以合資股權形式擁有位於倫敦市中心的 66 Shoe Lane，總樓面面積約300 萬平方呎，讓投資者可直接投資於優質甲級寫字樓及零售物業。信託自2023年榮獲全球房地產GRESB可持續的最高五星級別。冠君產業信託管理人乃鷹君資產管理（冠君）有限公司，為鷹君集團的成員。網站: www.championreit.com Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月4日 - (亞太商訊 via SeaPRwire.com) - 華營建築有限公司（「華營建築」）憑藉在企業社會責任（CSR）的持續投入，於建造業議會主辦的「建造業義工嘉許禮2025」中，榮獲三項殊榮，包括「CISVP全年最積極企業大獎 - 企業組（組別二）金獎」、「評審嘉許 - 卓越建造業義工（優異獎）」及「評審嘉許 - 優秀社福機構協作（優異獎）」。這一系列榮譽，充分印證華營建築將關愛文化融入企業血脈，並與員工、社區夥伴攜手貢獻社會的堅定承諾。「建造業義工嘉許禮」由議會轄下的「建造業運動及義工計劃」（CISVP）舉辦，旨在表揚及肯定業界義工及機構的無私奉獻，並推廣「建義勇為」的關愛精神，共建和諧社會。 「CISVP全年最積極企業大獎」是嘉許企業在過去一年積極組織及參與義工服務的殊榮；而「卓越建造業義工」及「優秀社福機構協作」兩項評審嘉許，則分別表彰了義工個人的傑出貢獻，以及公司與社福界夥伴的成功合作模式。 華營建築囊括此三項大獎，是對公司從企業層面、員工參與到跨界協作的全方位義工服務體系的權威認可。華營建築董事總經理潘樹杰先生強調：「我們深信，企業的價值不僅在於建造優質的樓宇，更在於建設一個充滿關愛的社會。這些獎項屬於每一位利用工餘時間服務社群的華營同事，也屬於與我們並肩同行的社福機構夥伴。這份榮譽將激勵我們繼續秉持『以人為本』的理念，發揚『建義勇為』的精神，將專業與愛心結合，為香港社會注入更多正能量。」華營建築在「建造業義工嘉許禮2025」上，榮獲「CISVP全年最積極企業大獎 - 企業組（組別二）金獎」企業的關懷精神，不僅體現在對外的社區服務，更植根於對內的員工福祉。作為此理念的生動實踐，公司早前舉辦的年度「炎夏展關懷」行動，便是一個具體例子。 期間，管理層親率團隊深入各大工地，為前線工友派發防暑裝備與清涼物資，以務實舉措守護勞動者的職場健康。 這項行動與公司推動義工服務的初心一脈相承，皆以人為本，旨在為勞動者及社區民眾創建一個安全、健康、有尊嚴的環境。在「炎夏展關懷」行動中，華營建築管理層與前線工友親切互動。感謝工友們的辛勤付出，你們是我們最重要的合作夥伴。面向未來，華營建築將繼續堅守企業公民責任，深化與各界持份者的合作，並鼓勵更多員工投身義工行列。公司將承載著業界的嘉許與社會的期望，繼續在拓展業務的同時，積極回饋社會，為香港的繁榮與和諧發展貢獻力量。在「建造業義工嘉許禮2025」現場，我們一同見證榮譽的誕生，分享每一份喜悅，並為業界的關愛精神和卓越成就感到驕傲。關於華營建築有限公司華營建築有限公司於1967年成立，為華營建築集團控股有限公司的間接全資附屬公司，在香港從事建築業多年，累積豐富本地建築市場經驗，成為一所具聲譽及客戶信賴的承建商。2014年1月，浙江省建設投資集團有限公司收購華營，成為華營的最終母公司。2019年10月，華營建築集團控股有限公司於香港聯交所主板上市。華營建築對外承接多項具代表性之工程項目，當中包括白田邨第十三期公營房屋重建項目、啟德1E區1號公營房屋發展項目、運用組裝合成建築法(MiC) 的洪水橋及荃灣聯仁街過渡性房屋項目、觀塘市中心第二及第三區住宅綜合發展項目、灣仔軒尼詩道1號(One Hennessy)、麗晶酒店翻新工程、多座數據中心、各大專院校，包括香港中文大學、香港科技大學和香港理工大學在內的教學及科研樓、宿舍等，所承建之項目屢獲殊榮。媒體聯繫黃先生電話：+852 3750 5785郵箱：media@czcgl.com.hk Copyright 2025 亞太商訊 via SeaPRwire.com.

紐約, 2025年8月4日 - (亞太商訊 via SeaPRwire.com) - Traveler Care 是一項突破性的醫療派遣平台，能將緊急醫療服務直接送達旅客所在的飯店、Airbnb 或度假租屋。該平台現已在全球正式推出，為旅遊保險公司提供一項高效解決方案，有效降低不必要的急診與住院索賠。Traveler care traveler.care首頁急診室的管家式替代方案Traveler Care 將旅遊保險公司及其保戶，與一個由持照醫療人員組成的待命服務網絡連結起來，這些醫療人員可在 60 至 90 分鐘內前往旅客下榻的住宿地點（如飯店或民宿）提供診療服務。流感、食物中毒、脫水、過敏反應、泌尿道感染、扭傷及傷口處理等常見病症，皆可於現場直接治療，無需前往急診室。「大多數情況下，旅客需要的只是醫生，而不是住院治療，」Traveler Care 創辦人 Eli Ofel 表示。「我們打造了一套可擴展、保險公司即刻可用的解決方案，不僅節省成本，也大幅提升了旅客的就醫體驗。」每次就診可減少逾一萬美元的保險理賠一般非緊急的急診室就診，平均會讓旅遊保險公司支出 13,000 至 17,000 美元。Traveler Care 可在旅客住宿現場，以 1,700 至 3,000 美元的價格處理相同病況，服務內容包括行動 X 光、超音波、靜脈注射與傷口處理等診斷與治療。試點項目結果顯示：-急診理賠案件數量減少 83%-每避免一宗急診案件，平均節省超過 10,000 美元-旅客滿意度顯著提升專為旅遊保險合作夥伴打造Traveler Care 完全為保險整合而設計，提供白標品牌與 API 選項，適用於第三方理賠機構（TPA）、承保人與全球救援網絡。平台特色包括：-美國全國範圍涵蓋（國際擴展計劃中）-強大的醫療派遣網絡，例如 Leaa Health、Sickday、Heal、DocGo 等公司——針對旅遊保險需求量高的地點，Traveler Care 可在 60 天內建立當地解決方案-符合 HIPAA 隱私法規的文件處理與一鍵理賠整合功能-支援服務地點涵蓋飯店、Airbnb、度假村與服務式公寓全球旅遊保險公司現正招募合作中「我們相信，旅遊保險公司不該只是支付醫療費用，而應該用更聰明的方式提供照護，」創辦人 Ofel 表示。「透過 Traveler Care，您能在不犧牲醫療品質的前提下，降低理賠金額。」誠邀保險公司、TPA 與全球救援公司加入合作，將上門急診服務納入其醫療保障體系的一部分。聯絡方式預約私人展示或索取投資報酬案例研究報告：網站： www.traveler.care 電郵： partners@traveler.care 電話： +1 (347) 733-0563關於 Eli OfelEli Ofel 是一位連續創業家與願景實踐者，曾創立多個運用人工智慧與科技驅動的醫療、金融與交通平台。他是 Traveler Care、Run.Vet、Leaa Health、02.Market與 Lender.Market 的創辦人及執行長。擁有超過 20 年在醫療運營、保險流程與行動物流領域的經驗，Ofel 能夠有效橋接病患需求與可擴展的平台解決方案，節省時間、成本，甚至拯救生命。聯絡方式Eli OfelCEOeli@traveler.care3477330563來源: Traveler care Copyright 2025 亞太商訊 via SeaPRwire.com.

HONG KONG, Aug 4, 2025 - (ACN Newswire via SeaPRwire.com) - The “Waste-to-Value, Industry Upgrade, and GBA Co-Creation” Technology Forum (the “Forum”), jointly organized by the GBA Economic and Trade Association, GBA Institute, All-China Environment Federation, and “The Hong Kong University of Science and Technology (HKUST) – Absolute Pure EnviroSci Limited (APEL) Joint Laboratory on Health and Environmental Innovation” under APEL, was successfully convened on 29 July 2025 in Hong Kong. The Forum gathered nearly a hundred innovation and technology experts, industry leaders, and business professionals to explore forward-looking topics such as solid waste management and advanced materials application, smart manufacturing for industry upgrade, low-carbon building materials, policy coordination across Guangdong-Hong Kong-Macao, and leading-edge advances in smart water quality monitoring and purification. By harnessing technological innovation, the Forum seeks to invigorate the circular economy and inject new momentum into the sustainable development of the Greater Bay Area (GBA).The event was graced by an illustrious roster of speakers and honored guests, including Miss Diane Wong, JP, Under Secretary for Environment and Ecology Bureau, the Government of the Hong Kong Special Administrative Region (HKSAR); Mr. Liu Kun, Deputy General Manager, Hunan Construction Investment Group ; Dr. David Chung, Chairman of APEL; Prof. Daniel Cheng, BBS, MH, JP, Honorary President and GBA Honorary Fellow, GBA Economic and Trade Association; Mr. Chan Wing Fai, Deputy Director, All-China Environment Federation; Prof. Yeung King Lun, Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST. These distinguished guests provided strategic and multi-faceted insights into policy, industry, green innovation, and cross-regional collaboration, offering forward-looking recommendations to support the high-quality development of the Greater Bay Area.Miss Diane Wong, JP, Under Secretary for Environment and Ecology Bureau, the Government of HKSAR, said, “To drive the low-carbon transition and seize the economic opportunities presented by green development, Hong Kong has established a robust collaborative framework with Mainland cities in the Guangdong-Hong Kong-Macao Greater Bay Area, actively exploring a regional co-operation model for a ‘Zero-Waste City.’ By harnessing their complementary regional strengths, the Mainland and Hong Kong enhance the recovery and recycling of materials in the Greater Bay Area, thereby advancing the circular economy. Through innovation, partnership, and supportive policies, we can transform environmental challenges into new opportunities. I hope today’s discussion will spark innovative ideas and create more opportunities for collaboration, allowing us to work hand in hand toward a greener future.”Mr. Liu Kun, Deputy General Manager, Hunan Construction Investment Group, highlighted, “The future of technology belongs to courageous pioneers. By uniting the wisdom of ‘Transforming Waste into Value,’ the spirit of ‘Industry Upgrade,’ and the vision of ‘GBA co-creation,’ we will harness the multi-sectoral advantages of investment and infrastructure and make lasting contributions to Hong Kong’s high-quality and sustainable development.”Dr. David Chung, Chairman of APEL, stated, “Technology is the driving force behind economic transformation and higher competitiveness in the new era. By harnessing the power of technology, we seek to ‘Transform Waste into Value’, promote industry upgrades, and accelerate green development. Hong Kong is uniquely positioned—through its entrepreneurial spirit, innovative technologies, robust infrastructure, and global connectivity—to nurture a world-class industrial ecosystem. It is vital that government, industry, academia, research, and investment sectors collaborate closely to advance smart manufacturing, green technology, and high-end manufacturing, while deepening synergies with other cities in the GBA. APEL will continue to align with government policies, foster technological integration and environmental innovation, positioning Hong Kong as a model for new industrialization, driving sustainable development locally and globally.”Prof. Daniel Cheng, BBS, MH, JP, Honorary President and GBA Honorary Fellow, GBA Economic and Trade Association, emphasized “We believe that technological innovation is the cornerstone for high-quality regional economic growth. Today’s forum marks an important step toward a greener, smarter, and more sustainable future. By applying intelligent solid waste processing and resource regeneration technologies, we can significantly reduce environmental burden of waste and transform it into high-value new materials, extending the value chain for green industries and contributing to national goals of carbon peaking and neutrality.”The Forum gathered nearly a hundred innovation and technology experts, industry leaders, and business professionals, including Miss Diane Wong, JP, Under Secretary for Environment and Ecology Bureau, the Government of the HKSAR (fifth from the right); Mr. Liu Kun, Deputy General Manager, Hunan Construction Investment Group (fourth from the right); Mr. Jackin Jim, Chairman of Yee Hop Holdings Limited (fifth from the left); Dr. David Chung, Chairman of APEL (third from the right); Dr. Pat Yeung, Director of APEL (forth from the left), Dr. Willie Lai, Founder of the GBA Economic and Trade Association (first from the left); Prof. Daniel Cheng, BBS, MH, JP, Honorary President and GBA Honorary Fellow, GBA Economic and Trade Association (third from the left); Mr. Chan Wing Fai, Deputy Director, All-China Environment Federation (second from the right); Dr. Chen Weiguang, Director, Digital Low-Carbon Research Institute, Institute of Innovation and Development of Sciences and Technology, Chinese Academy of Sciences (first from the right); and Prof. Yeung King Lun, Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST (second from the left)Fly Ash Recycling Technology Emerges as Key Engine for Circular Economy Development in Greater Bay AreaThe subsequent “Waste-to-Value, Industry Upgrade, and GBA Co-Creation” technology forum brought together experts and industry leaders from various fields for in-depth discussions on three major themes, injecting fresh insights into green technology and regional industrial upgrading. China’s Solid Waste Pollution Prevention and Control Law mandates the safe disposal and resource utilization of fly ash to minimize environmental pollution. Ms. Huang Jing, Deputy Manager, Overseas Division, Hunan Construction Investment Group, analyzed the advantages and case studies of multi-source solid waste (including fly ash and sludge) treatment and integration with new materials.Dr. Chen Weiguang, Director of the Digital Low-Carbon Research Institute, Institute of Innovation and Development of Sciences and Technology, Chinese Academy of Sciences, highlighted that since 2030, China has been progressively reducing landfill disposal of fly ash, encouraging regions with the necessary conditions to achieve zero landfill for incineration residues. Conventional chelation and landfill methods for fly ash—which contains chlorides, heavy metals, and dioxins—are being replaced by innovative two-step processing technology. This approach enables high-value resource recovery, establishing a complete industrial value chain and offering a scalable, replicable solution for near-zero solid waste landfill globally.At the forum, moderator Dr. David Chung, Chairman of APEL (left), together with Dr. Chen Weiguang, Director, Digital Low-Carbon Research Institute, Institute of Innovation and Development of Sciences and Technology, Chinese Academy of Sciences (center) and Ms. Huang Jing, Deputy Manager, Overseas Division, Hunan Construction Investment Group (right) engaged in a discussion on waste resource utilization and circular technologies.In the realm of new industrialization and smart manufacturing, Ir. Raymond Shan, General Manager, New Industrialisation Division, Hong Kong Productivity Council (HKPC), and Dr. Alex Choi, Biomedical Specialist, New Industrialisation Division, HKPC shared insights on how automation, digitalization, and AI-driven solutions are advancing upgrade of industries. Ir. Raymond Shan, General Manager of the New Industrialisation Division of HKPC, stated: “Hong Kong is entering a 'New Quality Era'. The HKSAR Government has launched the 'New Industrialisation Funding Scheme (NIFS)' and 'New Industrialisation Acceleration Scheme (NIAS)', which aim to subsidise enterprises engaged in smart and green manufacturing to establish new smart production lines in Hong Kong. HKPC is also cultivating future engineers through a series of future skills training programs, while promoting development in emerging fields such as new energy, bio-health, advanced manufacturing, new materials and artificial intelligence, to consolidate Hong Kong's position as an international innovation hub.”Dr. Alex Choi, Biomedical Specialist of the New Industrialisation Division of HKPC, stated: “In HKPC's initiatives and projects to commercialize R&D achievements in Hong Kong's life & health and new energy industries, we have collaborated with a local enterprise to promote the development of the hydrogen energy sector. The plan includes building Hong Kong's first green hydrogen production facility that will utilize natural biogas from landfills to produce hydrogen. The hydrogen produced at this facility complies with the GB/T 37244-2018 quality standard with purity ≥99.97%, and is suitable not only for transportation use but also for various downstream applications.”At the forum, moderator Dr. David Chung, Chairman of APEL (left), together with Ir. Raymond Shan, General Manager, New Industrialisation Division, HKPC (center) and Dr. Alex Choi, Biomedical Specialist, New Industrialisation Division, HKPC (right) engaged in a discussion on new industrialization and smart manufacturing.On innovative smart water management, Prof. Han Wei, Research Associate Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST, along with Mr. Billy Luk, Chief Application Scientist at the HKUST–APEL Joint Laboratory, presented the latest breakthroughs in smart water quality monitoring and efficient purification technologies. Mr. Billy Luk said, “Water is an essential resource for sustaining human life and ecological health. Wisepura Aquapura, developed by APEL, utilizes world’s first patented porous silica capsule technology, which intelligently releases active ingredients upon contact with water. This effectively targets over 30 types of over 30 types of bacteria, fungi, and viruses in water supply, air conditioning, and sewage systems while also meeting diverse application needs. Currently, this innovative technology is widely applied across Hong Kong’s public infrastructure. More importantly, the silica capsule can be reused multiple times and safely disposed of at the end of its lifecycle, thereby minimizing environmental impact.”Prof. Han Wei, Research Associate Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST (left) and Mr. Billy Luk, Chief Application Scientist at the HKUST–APEL Joint Laboratory (right) presented the latest breakthroughs in smart water quality monitoring and efficient purification technologies at the forum.About All-China Environment FederationAll-China Environment Federation (ACEF) is a nationwide non-profitable civil society organization (CSO) in the field of the environment, and is supported by the government. It is composed of CSOs and individuals who are enthusiastic about and support environmental protection and are willing to work for it. The objective of ACEF is to serve as a bridge between the government and the public in implementing the sustainable development strategy, achieving national objectives on environment and development, and protecting the environmental rights of the public. By fully utilizing its organizational advantage, ACEF aims to promote environmental protection and sustainable development in China and the world at large.About GBA Economic and Trade AssociationThe GBA Economic and Trade Association is an economic, trade and financing matching platform initiated and established by business leaders and social elites. Its vision and mission is to cooperate with national policies, assist the economic development of the Greater Bay Area, and provide diversified policy research, analysis and advice, make use of the different advantages and resources of different regions in the region, strengthen economic and trade cooperation, open up four streams: talent flow, goods flow, capital flow and information flow, and accelerate the development of the Bay Area into a world-leading economy.About GBA InstituteThe GBA Institute, founded by the GBA Economic and Trade Association, aims to support the national strategy for the Greater Bay Area's development. Its mission is to cultivate global business leaders and uphold Hong Kong's position as a leading international financial center. The institute partners with prestigious global universities to offer high-level training programs and recognizes outstanding contributors from politics, business, and academia who have made significant contributions to society and the development of the Greater Bay Area.About Absolute Pure EnviroSci LimitedAbsolute Pure EnviroSci Limited (“APEL”), is an indirect non-wholly owned subsidiary of Yee Hop Holdings Limited, a company listed on the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 1662.HK). With a mission to improve the quality of life and living environments, APEL is principally engaged in the research and development and commercialization of health and environmental innovations. Leveraging its Multilevel Antimicrobial Polymer (MAP-1) technology, APEL has developed specialized application formulas in four key areas: air purification in aircraft, water purification, livestock health, and eco-friendly building materials, all designed to address pressing global challenges. On 10 January 2024, APEL jointly established the “HKUST-APEL Joint Laboratory on Health and Environmental Innovation” with the Hong Kong University of Science and Technology (HKUST) to develop and translate novel discoveries into groundbreaking health and environmental innovations. APEL looks forward to working with researchers and industry partners worldwide to drive further health and environmental innovations. To tap into the global health and environmental hygiene market, APEL is currently holding an innovative interactive exhibition at The Lab. in Osaka to showcase its three flagship products—Wisepura water and air purification systems, GERMAGIC™ antimicrobial coating, and GERMAGIC™ PET health care solutions for pets—seizing growth opportunities in Asia’s health technology industry.For inquiries, please contact:AJA (IR & Communications)Avy YuTel: (852) 9500 4443Email: avy.yu@ajacapital.com.hk / info@ajacapital.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年8月4日 - (亞太商訊 via SeaPRwire.com) - 由大灣區經貿協會、大灣區學院、中華環保聯合會及Absolute Pure EnviroSci Limited（「APEL」）旗下「香港科技大學--APEL環境科學健康與環境創新聯合實驗室」聯合主辦的「化廢為寶、產業升級、灣區共創」科技論壇於2025年7月29日在香港盛大舉行，吸引近百位科創界權威、行業領袖及商界精英共襄盛舉，聚焦固廢治理與新材料應用、智能製造賦能工業升級、低碳建材創新應用、粵港澳政策協同及智能水質監測與淨化科技等前沿議題，以科技創新驅動循環經濟，為大灣區可持續發展注入新動能。本次活動特邀多位行業標杆人物發表演講，包括香港特別行政區政府環境及生態局副局長黃淑嫻女士, JP、湖南建投六建集團副總經理劉坤先生、APEL主席鍾偉强博士、大灣區經貿協會榮譽會長及大灣區榮譽院士鄭文聰教授, BBS, MH, JP、中華環保聯合會副主任陳永暉先生，以及香港科技大學化學及生物工程學系、環境及可持續發展學部教授楊經倫教授。多位嘉賓從政策、產業、綠色創新與區域協作等多角度剖析灣區機遇，為大灣區高質發展建言獻策。香港特別行政區政府環境及生態局副局長黃淑嫻女士表示：「為推動低碳轉型並及時把握綠色發展帶來的經濟機遇，香港已與粵港澳大灣區內地城市建立固定的合作機制，積極探索「無廢城市」區域共建模式。兩地以區域優勢互補策略，推動大灣區可回收物料的資源化利用，共同發展循環經濟。通過創新、合作和政策引導，我們將能把環保挑戰轉化為新的機遇。希望今天的討論能夠激發更多的創新思維和合作機會，讓我們攜手共創綠色未來。」湖南建投六建集團副總經理劉坤先生指出：「科技的未來屬於敢於突破的實踐者，我們能將『化廢為寶 』的智慧、『產業升級』的魄力、『港區共創』的格局融成一體，充分發揮投資與基建的多領域優勢，為香港可持續高質量發展做出貢獻。」APEL 主席鍾偉强博士表示：「科技是推動新時代經濟轉型和提升競爭力的關鍵引擎。我們要善用科技力量，實踐『化廢為寶』，推動產業升級和綠色發展。香港憑藉企業家精神、創新技術、完善基建和國際連繫，具備打造世界級產業集群的獨特優勢。在新時代的發展格局中，官、產、學、研、投五方應緊密合作，推動智能製造、綠色科技和高端製造業，加強與大灣區城市的聯動。APEL 將繼續配合政府政策，促進科技融合與環保創新，助力香港成為新型工業化的典範，為本地以至全球的可持續發展注入新動力。」大灣區經貿協會榮譽會長及大灣區榮譽院士鄭文聰教授表示：「我們深信科技創新是推動區域經濟高質量發展的核心動力，今天的論壇正是我們邁向綠色、智慧、可持續未來的重要一步。通過智能化的固廢處理和資源再生技術，不僅能大幅減少廢棄物對環境的壓力，還能將其轉化為高附加值的新材料，推動綠色產業鏈的延伸，有效助力國家『碳達峰、碳中和』目標的實現。」本次活動吸引近百位科創界權威、行業領袖及商界精英共襄盛舉，出席嘉賓包括香港特別行政區政府環境及生態局副局長黃淑嫻女士, JP（右五）、湖南建投六建集團副總經理劉坤先生（右四）、義合控股有限公司主席詹燕群先生（左五）、APEL主席鍾偉强博士（右三）、APEL董事楊學光博士（左四）、大灣區經貿協會創辦人賴國偉博士（左一）、大灣區經貿協會榮譽會長及大灣區榮譽院士鄭文聰教授, BBS, MH, JP（左三）、中華環保聯合會副主任陳永暉先生（右二）、中國科學院北京中科科技創新發展研究院數字低碳研究所所長陳偉光博士（右一），以及香港科技大學化學及生物工程學系、環境及可持續發展學部教授楊經倫教授（左二）。飛灰資源化技術勢成推動大灣區循環經濟發展的關鍵引擎隨後進行的「化廢為寶、產業升級、灣區共創」科技論壇，匯聚多位來自不同領域的專家學者與業界代表，圍繞三大主題進行深入交流，為綠色科技與灣區產業升級注入嶄新洞見。《中華人民共和國固體廢物污染環境防治法》等法律法規對飛灰的處置和利用作出了明確規定，要求對飛灰進行無害化、資源化利用，减少對環境的污染。湖南建投六建集團海外公司副經理黃菁女士詳細剖析飛灰、污泥等多源固廢綜合治理與新材料融合的優勢及案例。中國科學院北京中科科技創新發展研究院數字低碳研究所所長陳偉光博士指出，2030年起全國逐步減少飛灰填埋量，鼓勵實現零填埋。針對飛灰中的氯鹽、重金屬等污染物，現有整合填埋方式將被創新技術取代，通過二步法工藝實現資源化轉型，構建完整產業價值鏈，為全球固廢近零填埋提供可行路徑。論壇主持人APEL主席鍾偉强博士（左）與中國科學院北京中科科技創新發展研究院數字低碳研究所所長陳偉光博士（中）及湖南建投六建集團海外公司副經理黃菁女士（右）共同探討廢物資源化與循環科技。在新型工業化與智能製造方面，香港生產力促進局新型工業化部總經理單銘賢工程師及生物醫學專家顧問蔡永達博士分享了自動化、數字化和AI驅動的工業升級方案。香港生產力促進局新型工業化部總經理單銘賢工程師表示：「香港正邁向『新質時代』，特區政府推出的『新型工業化資助計劃（NIFS）』和『新型工業加速計劃（NIAS）』，旨在資助智能及綠色製造的企業在香港設立新智能生產線。生產力局亦通過提供一系列未來技能培訓培育未來工程師，並推動新能源、生物健康、先進製造、新材料及人工智能等新興領域的發展，鞏固香港國際創新中心地位。」香港生產力促進局新型工業化部生物醫學專家顧問蔡永達博士表示：「生產力局在推動香港生命健康及新能源產業研發成果商業化所進行的措施和項目中，與一家本地企業合作以促進氫能產業的發展，計劃興建香港首座綠色製氫設施，利用堆填區產生的天然沼氣製氫。該設施所生產的氫氣符合GB/T 37244-2018質量標準，純度≥99.97%，除了供交通運輸使用，亦適用於其他下游應用場景。」論壇主持人APEL主席鍾偉强博士（左）與香港生產力促進局新型工業化部總經理單銘賢工程師（中）及香港生產力促進局新型工業化部生物醫學專家顧問蔡永達博士（右）共同探討新型工業化與智能製造議題。關於智能水務創新成果，香港科技大學化學及生物工程學系、環境及可持續發展學部副教授韓偉教授及香港科技大學 (HKUST)--Absolute Pure EnviroSci Limited (APEL) 聯合實驗室首席應用科學家陸朗霆先生則分享了智能水質監測及高效淨化技術的最新突破。陸朗霆先生表示：「水資源是維繫人類生命與生態環境健康的關鍵。APEL 研發的 Wisepura Aquapura 採用了全球首創的多孔結構矽微囊專利技術，與水接觸時智能控釋其活性物質，有效針對供水系統、空調系統及下水道系統中超過 30 種細菌、真菌及病毒，同時滿足多種應用場景的需求。目前，這項創新技術已在香港多處公共基礎設施廣泛應用。更重要的是，矽微囊系統可多次循環使用，且在使用壽命結束後能安全處理，有效減輕環境負擔。」香港科技大學化學及生物工程學系、環境及可持續發展學部副教授韓偉教授（左）及香港科技大學 (HKUST)--Absolute Pure EnviroSci Limited (APEL) 聯合實驗室首席應用科學家陸朗霆先生（右）於論壇上分享了智能水質監測及高效淨化技術的最新突破。關於中華環保聯合會中華環保聯合會是經國務院批准、民政部註冊，生態環境部為行業管理部門，由熱心環保事業的人士、企業、事業單位自願結成的、非營利性的、全國性的社團組織。中華環保聯合會的宗旨是圍繞實施可持續發展戰略，圍繞實現國家環境與發展的目標，圍繞維護公眾和社會環境權益，充分體現中華環保聯合會「大中華、大環境、大聯合」的組織優勢，發揮政府與社會之間的橋梁和紐帶作用，促進中國環境事業發展，推動全人類環境事業的進步。關於大灣區經貿協會大灣區經貿協會是由社會精英倡導創立的經濟貿易及融資配對平台，願景及使命是配合國家政策，致力推動大灣區的經濟發展。積極為各個領域提供商業、經濟和融資配對服務，搭建起企業與政府、企業與企業之間的橋樑，促進大灣區成為全球領先的經濟體。關於大灣區學院大灣區學院由大灣區經貿協會創辦，目的是配合國家的粵港澳大灣區戰略規劃發展，培育環球企業領袖人才，維持香港作為首屈一指的國際金融中心；並與國際知名高等學府聯合舉辦高端人才培訓認證課程「大灣區院士」，與及頒授榮譽名銜予對社會及大灣區建設有傑出貢獻的政、商、學界知名人士。關於APELAbsolute Pure EnviroSci Limited（「APEL」）為香港聯合交易所主板上市公司--義合控股有限公司（香港主板上市編號：1662）的間接非全資附屬公司。以改善生活品質及居住環境為使命， APEL 主要從事健康與環境科技創新的研究、開發及商業化。基於其多層次殺菌塗層技術（MAP-1），APEL 已在四個關鍵領域：飛機空氣淨化、水質淨化、畜牧健康和環保建材，研發專門的應用配方，旨在應對全球迫切挑戰。2024 年 1 月 10 日，APEL與香港科技大學共同建立「香港科技大學--APEL 環境科學健康與環境創新聯合實驗室」，就創新的健康和環境技術進行研發及成果轉化。APEL 期待與全球研究人員和行業夥伴合作，推動更多健康與環境科技創新。為佈局國際健康與環境衛生的市場，APEL 現正於大阪 The Lab.舉行創新互動展覽會，展示三大旗艦產品--Wisepura 水質及空氣淨化系統、GERMAGICTM 抗菌塗層和 GERMAGICTM PET 寵物健康及護理方案，把握亞洲健康科技產業的發展機遇。如有垂詢，請聯絡：AJA (IR & Communications)庾婉華電話：(852) 9500 4443電郵：avy.yu@ajacapital.com.hk / info@ajacapital.com.hk Copyright 2025 亞太商訊 via SeaPRwire.com.